NCT00216398View on ClinicalTrials.gov

Lanreotide Autogel in Patients With Acromegaly Previously Treated With Octreotide LAR

PHASE4CompletedINTERVENTIONAL

Enrollment

8

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

June 22, 2006

Study Completion Date

June 22, 2006

Conditions

Acromegaly

Interventions

DRUG

Lanreotide (Autogel formulation)

Trial Locations (1)

2145

Westmead Hospital, Westmead

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Ipsen

INDUSTRY